Articles Posted in Mesothelioma Attorney

The Philadelphia school system recently agreed to a settlement in an asbestos cancer lawsuit with a long time teacher who claimed she developed a serious form of asbestos-related cancer as a result of working in dangerous conditions in the school system. As part of the settlement, the 30-year special education teacher will receive a total of $850,000 dollars to compensate her for her lost wages, medical bills, and pain and suffering of living with the disease.

According to the mesothelioma cancer lawsuit, filed in September 2019 in a Pennsylvania court in Philadelphia, the plaintiff worked in two 90-year-old, dilapidated school buildings with damaged asbestos pipe insulation. The plaintiff’s lawsuit recalls an instance where she came in direct contact with crumbling asbestos pieces, which she claims was one of the instances in which she was exposed to the deadly carcinogen which caused her mesothelioma cancer diagnosis. The plaintiff had hoped to continue working for at least another seven years but has been forced into retirement while she contemplates her treatment options moving forward in order to fight the disease.

Asbestos is a naturally occurring mineral and was once commonly used in a variety of industrial, construction, and military applications due to its heat resistant properties and ability to be shaped to fit a variety of needs, particularly in insulation for pipes. However, asbestos is also carcinogenic and is directly linked to developing mesothelioma, a rare and deadly form of cancer which affects thin linings of tissue surrounding vital organs such as the lungs, heart, and abdominal cavity. Mesothelioma is often not diagnosed until decades after exposure, which often leaves patients with diminished treatment options to fight the disease.

A New Jersey state jury recently handed down a substantial $750 million verdict to plaintiffs during the punitive damages phase of the trial after already handing down a multimillion dollar verdict on the victim’s behalf during the main phase of the trial last year. The four victorious plaintiffs brought their talcum powder asbestos cancer lawsuit against New Jersey-based pharmaceutical and cosmetics giant Johnson & Johnson, claiming the company knowingly sold cosmetics products containing deadly carcinogens.

In September 2109, a Middlesex County jury handed down a $37.3 million verdict on behalf of the plaintiffs after a nearly two-month trial, during which time they were presented with compelling testimony detailing Johnson & Johnson’s decades long knowledge about the possibility of asbestos contamination in its iconic Baby Powder. The cosmetic product is made from talc, one of the softest known minerals, and used in a variety of other products including Johnson & Johnson’s Shower to Shower.

Attorneys for the plaintiffs told jurors how the plaintiffs developed various forms of cancer, including mesothelioma, from years of using Johnson & Johnson’s Baby Powder. Jurors were presented with internal Johnson & Johnson documents which showed executives knew as far back as the 1970s that its talc-based products were testing positive for deadly asbestos fibers.

The National Institutes of Health recently bestowed a five-year $2.6 million grant to researchers at the University of Hawaii Cancer Center to examine the role that certain genes may play in asbestos-related cancer and whether certain cell mutations may play a role in the survival of patients. The research team will be led by esteemed researchers Michele Cabrone and Haining Yang and look into the role of the BAP1 gene in human cancer development and cell metabolism.

“This grant adds to our two already funded NIH grants and one grant from the Department of Defense, confirming the leadership of the Hawaii team as the top federally-funded research team in the U.S. to conduct research on mesothelioma, a cancer developed frequently in those exposed to asbestos,” said Carbone.

Carbone is distinguished for his discovery of the role that genes play in mesothelioma while studying a cancer epidemic in remote villages of Turkey. He and Yang further collaborated by studying mesothelioma genetics by conducting studies of families in the United States who have a high incidence of cancer, during which time they discovered a condition the pair termed “BAP1 cancer syndrome.”

On behalf of the state of New Mexico, Attorney General Hector Balderas recently filed suit against pharmaceutical and cosmetics giant Johnson & Johnson over claims that the company knew for decades about the risks posed by using its talc-based products but continued to market the product to consumers. The talcum powder lawsuit further alleges that Johnson & Johnson systematically targeted minority women in its advertising and marketing campaigns of its Baby Powder and Shower to Shower products and misled them and others about the safety of the products.

According to Attorney General Balderas, Johnson & Johnson “concealed and failed to warn consumers about the dangers associated with their talc products,” among which can include such diseases like lung disease, ovarian cancer, and mesothelioma, a rare and deadly cancer which commonly affects the thin lining of tissue surrounding vital organs such as the lungs, heart, and abdomen. The legal action by the state of New Mexico is just the latest in a series of claims brought against Johnson & Johnson, which currently faces an estimated 17,000 talcum powder cancer lawsuits across the country brought by plaintiffs who claim their serious health conditions were caused by decades of talc use.

Thus far, jurors in state courts from California, Missouri, and New Jersey have handed down a over $5 billion in compensation to dozens of plaintiffs who claim they suffered irreparable harm at the hands of Johnson & Johnson. In the wake of these lawsuits, Johnson & Johnson’s long-time talc supplier, Imerys Talc USA filed for bankruptcy under the weight of litigation and its liability for its role in these and other plaintiffs’ talcum powder asbestos cancer diagnosis.

A group of seven California plaintiffs recently signaled their intention to a federal court to refile their talcum powder asbestos cancer lawsuit against pharmaceutical and cosmetics giant Johnson & Johnson in order to include additional defendants who may be at fault for causing their asbestos-related conditions. The federal district court judge hearing the case granted plaintiffs their motion to dismiss the case and include plaintiffs such as Claire’s and Valeant Pharmaceuticals over those companies’ negligence for not placing appropriate warning labels on their products.

The plaintiffs sought the request after the judge hearing the case disallowed the group to make any further amendments to the complaint originally filed only against Johnson & Johnson over claims that it negligently marketed its talc-based products such as Baby Powder and Shower to Shower. The plaintiffs originally filed their complaint in U.S. District Court for the Central District of California, claiming that the group developed serious, asbestos-related medical conditions as a result of using Johnson & Johnson’s talc products.

The judge hearing the case allowed the group to dismiss their claims, without prejudice, with the added condition that they pay for the legal fees incurred by Johnson & Johnson in the first iteration of the lawsuit. However, the judge cautioned Johnson & Johnson against “overlawyering” in an attempt to inflate the costs of the case as a retaliatory measure against the plaintiffs. The federal judge himself will decide the total amount of legal fees owed to Johnson & Johnson.

A California state jury recently heard opening arguments in a new talcum powder asbestos cancer trial brought by a 48-year old woman who claims she developed her serious form of cancer after years of using talc-based products produced and marketed by the defendant. The mesothelioma cancer lawsuit claims pharmaceutical and cosmetics giant Johnson & Johnson knew its talcum powder products were contaminated with asbestos fibers but provided no warning to consumers about the dangers associated with using its products.

Attorneys for the plaintiff told jurors that for decades, the plaintiff was exposed to asbestos fibers in Johnson & Johnson’s Baby Powder and Shower to Shower and that was the cause of her developing mesothelioma cancer. Johnson & Johnson, on the other hand, maintained that despite the overwhelming evidence showing the company knew its products have tested positive for asbestos, those products are safe for consumers and not to blame for the plaintiff’s condition.

The trial comes just weeks after a Los Angeles jury handed down a substantial $40.3 million verdict to a plaintiff and her husband alleging the victim’s mesothelioma cancer was also caused by exposure to asbestos fibers in Johnson & Johnson’s Baby Powder. That latest lawsuit is just one of many that together have produced over $5 billion in total compensation to dozens of plaintiffs across the country who claim their cancer diagnoses were due to asbestos exposure from decades of using Johnson & Johnson’s talc-based products.

A Southern California jury recently awarded a former pipefitter and his wife $3 million in an asbestos cancer lawsuit brought against a contractor whom the plaintiff claims frequently exposed him to asbestos during the course of his employment. The mesothelioma lawsuit claimed that D.W. Nicholson Corp. exposed the plaintiff to asbestos while performing an estimated 100 contracting jobs at the Masonite Corp. in Ukiah, California.

According to the mesothelioma cancer lawsuit, filed in Los Angeles Superior Court, D.W. Nicholson Corp. installed mechanical, electrical, and piping equipment at Masonite more than 100 times while the plaintiff worked at the site. The plaintiff alleged that D.W. Nicholson frequently exposed the victim to asbestos when the company failed to clean up asbestos-containing debris it left behind and provided no warning to Masonite workers about the risks of exposure.

As a result of years of asbestos exposure from 1964 to 1999, the plaintiff claimed he developed mesothelioma, a rare and deadly form of cancer which commonly affects the thin lining of tissue surrounding vital organs like the lungs, heart, and abdominal cavity. Asbestos exposure is directly linked to developing this rare type of cancer, often occurring through industrial exposure in the course of employment or sometimes secondhand when fibers are brought home on work clothing.

A New York City judge recently handed down an important ruling in a mesothelioma cancer lawsuit allowing the plaintiff’s claim against a boiler company to continue rebuffing the defendant’s legal maneuvers to have the case dismissed before it could be heard by a jury. Attorneys for defendant Kohler Co. asked the judge to throw out the case on summary judgement, claiming there was a similar case in New York’s asbestos courts, which barred the plaintiffs from suing the company.

The case was brought by a retired clean up crew worker who worked from 1958 to 1966 and was responsible for removing boiler parts manufactured by Kohler Co. after they had been disassembled. The plaintiff eventually developed mesothelioma and filed a lawsuit against Kohler Co., claiming that he frequently came in contact with frayed gaskets that contained asbestos. The plaintiff ultimately passed away after his battle with mesothelioma in 2016, leaving his estate to take up the claim in court.

In their mesothelioma cancer lawsuit, the plaintiffs claimed that Kohler Co. should have known that maintenance companies would repair and replace boilers with parts manufactured with deadly asbestos fibers. In their motion for summary judgement, attorneys for the defendant pointed out that Kohler Co. did not manufacture the asbestos-laden parts itself and that the removal of parts after dismantling was not a foreseeable use of the product and that therefore the company owed no duty of care to anybody who was carrying parts away.

A California jury recently handed down a substantial award to a husband and wife who claim the man’s employer is responsible for his mesothelioma diagnosis developed while working at several of the defendant’s oil refineries over a two-decade period. The mesothelioma cancer lawsuit named Fluor Enterprises Inc., Middle East Fluor, the National Iranian Oil Company, and several other companies as defendants, claiming that the groups exposed the victim to carcinogens by using asbestos-laden products despite knowing of the risks to workers.

According to the asbestos cancer lawsuit, filed in Los Angeles County Superior Court, the plaintiff developed an especially rare form of testicular mesothelioma as a result of working with asbestos contaminated parts as part of his routine job duties on oil rigs. The plaintiffs claimed the defendants violated their own internal standards for safety in the process of completing those projects, cutting many corners and putting the victim and other workers at risk of asbestos exposure.

The Los Angeles jury ultimately sided with the plaintiffs, handing down a total of $25 million in compensatory damages to the couple. Of that award, $14 million was awarded to the husband for his past and future pain and suffering while the remaining $11 million went to the wife for her damages as a result of her spouse’s mesothelioma diagnosis. In apportioning liability to the defendants, the jury determined the Iranian National Oil Company to be 20% at fault and prescribed the remainder of the blame to the Flour companies.

A grieving Georgia family recently filed an asbestos talcum powder cancer lawsuit against Johnson & Johnson after losing their mother to a battle with mesothelioma in 2017 that they claim was caused by the pharmaceutical and cosmetics giant’s negligence. The family’s lawsuit against Johnson & Johnson and its supplier, Imerys Talc USA, comes just shortly after a report by Reuters detailed a review of thousands of internal company documents showing that the defendants knew for decades about asbestos contamination in its talcum powder products.

According to the talcum powder mesothelioma lawsuit, the victim used talc-based products manufactured by Johnson & Johnson and supplied by Imerys Talc USA that were contaminated with deadly asbestos fibers. Despite knowing full well about the presence of asbestos in its talcum powder products and the risks it could pose to consumers, the defendants declined to provide the public with any warnings on the product labels, according to the lawsuit.

The mesothelioma cancer lawsuit is another in an increasingly long list of claims filed against the company by defendants, mostly women, who developed ovarian cancer or mesothelioma as a result of using Johnson & Johnson talcum powder products. Currently, there are an estimated 12,000 other talcum powder cancer lawsuits against Johnson & Johnson pending in state and federal courts, with several slated for trial in 2019.

Contact Information